Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD541993Chairman, President & Chief Executive Officer
Wei hong Xiao-2016Chief Operating Officer
Bo Tan, MBA442009Chief Financial Officer & Executive Director
Zhenping Zhu MD, PhD-2017Chief Scientific Officer, President-R&D
Dong Mei Su, PhD462012Executive Director
Bin Huang, MBA561993Executive Director & Vice President
Dong Liu, MBA442014Non-Executive Director
Dong Lü, PhD422014Non-Executive Director
Tian Ruo Pu, MBA472014Independent Non-Executive Director
David R. Parkinson MD, PhD652014Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,532,313,570 1,060,972,150 41.9% 0 0.0% 41.9%
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 621,512,360 24.5%
Jing Lou, MD, PhD 599,367,030 23.7%
Bo Tan, MBA 116,849,920 4.61%
Dan Lou 62,001,010 2.45%
OppenheimerFunds, Inc. 42,165,000 1.67%
Bin Huang, MBA 32,197,350 1.27%
The Vanguard Group, Inc. 31,486,000 1.24%
Dong Mei Su, PhD 24,925,630 0.98%
BlackRock Fund Advisors 21,581,500 0.85%
HSBC Global Asset Management (Hong Kong) Ltd. 15,691,836 0.62%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
3SBIO INC. (ADR)0.00%3 589
BIOGEN INC-4.03%53 198
CSL LIMITED31.73%44 709
ALEXION PHARMACEUTICAL..-20.15%21 939
GRIFOLS SA31.81%17 451
BIOMARIN PHARMACEUTICA..6.23%15 355
CHONGQING ZHIFEI BIOLO..--.--%4 238
3SBIO INC45.00%3 589
ABCAM PLC27.90%2 564
JIANGXI BOYA BIO-PHARM..--.--%2 404
HUGEL INC--.--%1 328
BIOTEST AG71.92%1 071
PHARMA MAR SA53.51%1 033
PROMETIC LIFE SCIENCES..-10.53%1 015
ANIKA THERAPEUTICS INC-5.66%677
SYROS PHARMACEUTICALS ..22.78%402
CHEMOCENTRYX INC-6.76%332
SYNDAX PHARMACEUTICALS..80.20%236
STRONGBRIDGE BIOPHARMA..95.83%166
MEDIWOUND LTD51.77%153
CARDIOME PHARMA CORP46.97%138
Sector Biopharmaceuticals
3SBio Inc. (ADR) : Connections
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Hong Kong Sansheng Ltd.
UTStarcom, Inc.
Shenyang Sunshine Pharmaceutical Co., Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Liaoning Sunshine Science & Technology Development Co. Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
CFA Institute
Taizhou Huan Sheng Investment Management Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Collected Mind Ltd.
Excel Partner Holdings Ltd.
Ample Harvest Investments Ltd.
Shenzhen Baishitong Technology Development Co., Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Zyngenia, Inc.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
Beingmate Group Co. Ltd.
CITIC Industrial Investment Group Corp. Ltd.
The Multiple Myeloma Research Foundation, Inc.
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.25386000
Fax : +86.24.25811821
Web : www.3sbio.com
© 2017 People , Fundamentals and Ownership